| Affected Systems |
|
|
|
|
|
|
endocrine/exocrine glands
|
√
|
√
|
√
|
√
|
|
abnormal pancreatic alpha cell morphology
|
√
|
|
|
|
|
decreased pancreatic beta cell number
|
|
√
|
|
|
|
decreased pancreatic delta cell number
|
|
|
√
|
|
|
abnormal insulin secretion
|
|
|
|
√
|
|
decreased insulin secretion
|
|
|
√
|
√
|
|
increased insulin secretion
|
√
|
|
√
|
|
homeostasis/metabolism
|
√
|
|
√
|
√
|
|
homeostasis/metabolism phenotype
|
N
|
|
|
|
|
abnormal insulin secretion
|
|
|
|
√
|
|
decreased insulin secretion
|
|
|
√
|
√
|
|
increased insulin secretion
|
√
|
|
√
|
|
|
decreased circulating glucose level
|
|
|
√
|
√
|
|
increased circulating glucose level
|
|
|
|
√
|
|
increased circulating insulin level
|
|
|
√
|
|
|
impaired glucose tolerance
|
|
|
√
|
|
|
abnormal insulin clearance
|
|
|
√
|
|